Oscar Health Inc. (OSCR) Tops Q3 EPS by 20c

Oscar Health Inc. (NYSE: OSCR) reported Q3 EPS of ($0.29), $0.20 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.41 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Barclays Upgrades Oscar Health Inc (OSCR) to Overweight, 'we see a visible path to an undemanding 13–15x P/E valuation'
• Sharon AI surges premarket; New Oriental gains, Medline slips
• BIG3 Basketball to go public via Graf Global merger at $290 million